search

Active clinical trials for "Communicable Diseases"

Results 4531-4534 of 4534

Immunological Characteristics of Maternal-fetal Transmission of Cytomegalovirus in Pregnancy

PregnancyCytomegalovirus Infections1 more

Analysis of several characteristics of blood from pregnant women with CMV infection according to maternal-fetal transmission. These include CMV viral load, cytokine profile in response to in-vitro stimulation with CMV peptides, meticulous analysis of anti CMV antibodies, maternal DNA polymorphism and microarray of gene expression.

Unknown status5 enrollment criteria

Hospital Microbial Ecology Follow the Introduction of Ertapenem and Other Newly Introduced Antibiotic...

Infectious Diseases

This is a retrospective, multicentre, observational study to assess the trends in antibiotic utilization and hospital ecology with respect to susceptibility patterns of selected bacterial isolates to the utilized antibiotics.

Unknown status12 enrollment criteria

Acute Upper Respiratory Tract Infection - When is Bacteria Involved?

Acute Upper Respiratory Tract Infection and Acute Bacterial Rhinosinusitis

The purpose of this study is to find out if we can predict the progress of acute upper respiratory tract infection to acute bacterial rhinosinusitis in Finnish conscripts by symptoms, clinical, endoscopic or radiological findings, middle meatal swab samples or nitric oxide measurement.

Unknown status2 enrollment criteria

The Asia Cornea Society Infectious Keratitis Study

Corneal Ulcer

Corneal diseases are a major cause of blindness worldwide, and corneal infections are a substantial cause of blindness in Asia. The aim of the Asia Cornea Society Infectious Keratitis Study (ACSIKS) is to study infectious keratitis (corneal infections) in Asian countries, so as to improve strategies for prevention and treatment, and to reduce the burden of blindness in Asia. The first phase of ACSIKS is an 18-month observational study involving 11 eye hospitals in 8 Asian countries; these hospitals manage more than 6700 cases of corneal infections every year. From the first quarter of 2012, all patients with a corneal infection will be recruited and a standard ACSIKS protocol will be applied; this protocol includes the use of a common set of study forms and a suggested panel of microbiological examinations. However, each centre will be continue to treat their patients with the anti-infective therapy standard for their centre. Data will be recorded for each patient for a period of six months, including their medical and surgical management, the final clinical outcome and vision. Bacterial and fungal growths from patients will also be stored for further research during a second phase of ACSIKS. These studies will focus on evaluating the resistance of the most common bacterial infections to the current available antibiotics, performing DNA testing to compare our strains with bacterial infections in the West, and to developing new diagnostic tests and anti-infective therapies tailored to corneal infections in Asia.

Unknown status2 enrollment criteria
1...453454

Need Help? Contact our team!


We'll reach out to this number within 24 hrs